ARK Investment Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$98.4M Sell
3,053,818
-833,729
-21% -$30.9M 0.76% 38
2025
Q4
$164M Sell
3,887,547
-578,228
-13% -$23.3M 1.09% 30
2025
Q3
$153M Buy
4,465,775
+665,686
+18% +$19.1M 0.91% 30
2025
Q2
$103M Sell
3,800,089
-139,213
-4% -$4.03M 0.75% 37
2025
Q1
$117M Sell
3,939,302
-264,649
-6% -$10.1M 1.17% 25
2024
Q4
$166M Sell
4,203,951
-716,794
-15% -$27.1M 1.39% 22
2024
Q3
$168M Sell
4,920,745
-1,888,552
-28% -$53.1M 1.53% 20
2024
Q2
$148M Sell
6,809,297
-233,486
-3% -$4.91M 1.31% 25
2024
Q1
$156M Sell
7,042,783
-612,820
-8% -$15M 1.08% 28
2023
Q4
$211M Buy
7,655,603
+62,011
+0.8% +$1.5M 1.25% 23
2023
Q3
$170M Sell
7,593,592
-234,700
-3% -$6.04M 1.3% 21
2023
Q2
$199M Sell
7,828,292
-580,814
-7% -$14.1M 1.32% 21
2023
Q1
$188M Buy
8,409,106
+108,865
+1% +$2.63M 1.29% 22
2022
Q4
$197M Sell
8,300,241
-781,122
-9% -$18.2M 1.71% 21
2022
Q3
$151M Buy
9,081,363
+225,118
+3% +$5.07M 1.05% 25
2022
Q2
$156M Buy
8,856,245
+100,221
+1% +$2.02M 0.92% 28
2022
Q1
$241M Buy
8,756,024
+533,743
+6% +$15.3M 1.01% 27
2021
Q4
$339M Buy
8,222,281
+1,242,080
+18% +$54.9M 1.02% 30
2021
Q3
$324M Buy
6,980,201
+290,938
+4% +$12.7M 0.78% 31
2021
Q2
$267M Sell
6,689,263
-928,024
-12% -$39.7M 0.5% 52
2021
Q1
$409M Sell
7,617,287
-1,410,540
-16% -$81.2M 0.81% 36
2020
Q4
$442M Buy
9,027,827
+2,009,057
+29% +$93.1M 1.18% 29
2020
Q3
$228M Buy
7,018,770
+1,954,977
+39% +$62.1M 1.35% 24
2020
Q2
$131M Buy
5,063,793
+1,797,934
+55% +$44.8M 1.41% 23
2020
Q1
$79.4M Buy
3,265,859
+477,423
+17% +$12M 1.98% 17
2019
Q4
$77.9M Buy
2,788,436
+205,638
+8% +$5.32M 1.96% 18
2019
Q3
$62M Sell
2,582,798
-453,855
-15% -$12.1M 1.35% 25
2019
Q2
$86.6M Sell
3,036,653
-422,420
-12% -$10.6M 2.18% 13
2019
Q1
$86.5M Sell
3,459,073
-34,182
-1% -$653K 2.47% 12
2018
Q4
$43.9M Sell
3,493,255
-447,549
-11% -$5.29M 1.78% 24
2018
Q3
$37.6M Buy
3,940,804
+180,145
+5% +$1.99M 1.14% 33
2018
Q2
$35.1M Buy
3,760,659
+949,365
+34% +$6.68M 1.29% 28
2018
Q1
$15.6M Buy
2,811,294
+1,409,030
+100% +$8.72M 0.78% 43
2017
Q4
$9.16M Buy
1,402,264
+913,926
+187% +$6.79M 0.73% 46
2017
Q3
$4.28M Buy
488,338
+325,318
+200% +$2.65M 0.52% 53
2017
Q2
$1.36M Buy
163,020
+103,157
+172% +$841K 0.26% 55
2017
Q1
$550K Buy
59,863
+14,512
+32% +$119K 0.16% 60
2016
Q4
$351K Buy
+45,351
New +$339K 0.13% 62

Other funds holding VCYT

ARK Investment Management's VCYT Position: Q1 2026 in Review

ARK Investment Management reduced its Veracyte (VCYT) stake by 21% in Q1 2026, selling an estimated $30.9M and leaving 3,053,818 shares worth $98.4M. The position accounts for 0.76% of the portfolio, ranked #38.

ARK Investment Management first reported a position in VCYT in Q4 2016 and has held it in 38 quarters since. The position peaked at $442M in Q4 2020. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • ARK Investment Management held 3,053,818 shares of Veracyte worth $98.4M as of Q1 2026.
  • ARK Investment Management sold 833,729 Veracyte shares in Q1 2026, an estimated $30.9M.
  • Veracyte made up 0.76% of ARK Investment Management's portfolio in Q1 2026, its #38 holding.
  • ARK Investment Management first reported a position in Veracyte in Q4 2016 and has held it in 38 quarters since.
  • ARK Investment Management's Veracyte position peaked at $442M in Q4 2020.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on ARK Investment Management's 13F filing for Q1 2026, filed 12 May 2026.